Biblio

Author Title [ Type

] Year

Filters: Author is Sapienza, Giuseppe [Clear All Filters]

Journal Article

Salmanton-García J, Marchesi F, Farina F, Weinbergerova B, Itri F, Dávila-Valls J, Martín-Pérez S, Glenthøj A, Hersby DStampe, da Silva MGomes, et al. Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022. EClinicalMedicine. 2024;71:102553.

Pirosa MCristina, Leotta S, Cupri A, Stella S, Martino EAntonia, Scalise L, Sapienza G, Calafiore V, Mauro E, Spadaro A, et al. Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report. Chemotherapy. 2018;63(4):220-224.

Castagna L, Bono R, Tringali S, Sapienza G, Santoro A, Indovina A, Tarantino V, Di Noto L, Maggio A, Patti C. The place of allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma in the era of CAR-T-cell therapy. Front Med (Lausanne). 2022;9:1072192.

Leotta S, Pirosa MCristina, Markovic U, Scalise L, Bulla A, Sapienza G, Di Giorgio MAnn, Martino EAntonia, Pelle ACurto, Leotta V, et al. Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy. Chemotherapy. 2019:1-4.

Fresa A, Autore F, Piciocchi A, Catania G, Visentin A, Tomasso A, Moretti M, Vitale C, Chiarenza A, Morelli F, et al. Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. Blood Adv. 2022;6(13):3875-3878.